Skip to main content

Antimicrobial stewardship in critical care: Applying PK/PD and optimised antimicrobial dosing to improve care

Journal
Journal of critical care (Q1)
Published
13 November 2026
Study design
Narrative review / expert opinion
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Reena Mehta, Erin F Barreto, Andrew Conway Morris, Despoina Koulenti, Ryan C Maves, Margaret Pertzborn, et al.
PMID
43025027
DOI
10.1016/j.jcrc.2026.155817

Why clinicians should know about it

  • Picked for Nephrology (paper of the day, 16 November 2026): Addresses antimicrobial dosing with AKI and extracorporeal support

Abstract

Life-threatening infections are common in critically ill patients and remain a major cause of morbidity and mortality in the intensive care unit (ICU). Antimicrobial stewardship (AMS) aims to optimise antimicrobial use by balancing effective treatment with minimising toxicity, resistance and unnecessary exposure. This review examines AMS in critical care with a focus on antimicrobial dose optimisation. Core AMS principles in the ICU include diagnostic stewardship, appropriate antimicrobial initiation, de-escalation and treatment duration. Dose optimisation is fundamental but challenging because critical illness causes profound and dynamic changes in pharmacokinetics (PK) and pharmacodynamics (PD). These alterations result in marked interpatient variability and increase the risk of subtherapeutic or toxic drug exposure. Understanding key PK parameters, including volume of distribution, clearance and half-life, together with PD targets such as Cmax/MIC, fT > MIC and AUC0-24/MIC is essential for individualising therapy. Factors including sepsis, organ dysfunction, augmented renal clearance and extracorporeal support can substantially alter antimicrobial exposure and dosing requirements. Strategies to improve target attainment include loading doses, prolonged infusions, therapeutic drug monitoring and model-informed precision dosing, although implementation may be limited by local resources. Integrating PK/PD-informed dosing into routine ICU practice can improve clinical outcomes, reduce toxicity and strengthen AMS in critically ill populations.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.